# Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes

> **NCT00398853** · PHASE4 · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 100 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** chromium picolinate 1000 mcg daily vs placebo
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00398853
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398853, "Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00398853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*